Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer

Citation
M. Caputi et al., Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer, ANTICANC R, 19(1B), 1999, pp. 825-827
Citations number
11
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
1B
Year of publication
1999
Pages
825 - 827
Database
ISI
SICI code
0250-7005(199901/02)19:1B<825:FHEOBP>2.0.ZU;2-V
Abstract
Bax, bcl-2 and their homologues regulate a distal step in an evolutionary v ery well conserved pathway of apoptotic cell death. It plays a crucial role in the balance between proliferation rate and cell viability. Thus in the last pars the attention of the scientific community towards these proteins has remarkably increased, in particular in the oncologic field. We develope d an immunohistochemical assay allowing us to evaluate the bax expression i n formalin fixed and paraffin embedded lung cancer tissues to investigate b ax expression in a cohort of 55 patients affected by non-small cell lung ca ncer. We detected high expression of bax in 72.7% of our patients. When we statistically analyzed our data we did not find any correlation between bar expression and any clinicopathologic parameters (sex, age, TNM status tumo r grade, histological type). In conclusion, our study shows the frequent ov erexpression of bax, and this highlights the "apoptotic tendency" of cells during the neoplastic proliferation. But, the role of bar in non-small cell lung cancer pathogenesis still remains unclear and further studies of larg e numbers of patients, including different stage groups, are needed to bett er define the involvement of this protein in the complex mechanism of lung carcinogenesis.